A Randomized Controlled Trial to Examine the Posttreatment Efficacy of Neurofeedback, Behavior Therapy, and Pharmacology on ADHD Measures. Issue 4 (February 2019)

• Record Type: Journal Article
• Authors: Moreno-García, Inmaculada; Meneres-Sancho, Susana; Camacho-Vara de Rey, Carlos; Servera, Mateu
• Is Part Of: Journal of attention disorders. Volume 23:Issue 4(2019)
• Page Start: 374
• Page End: 383
• Publication Date: 2019-02
• Subjects: randomized controlled trial -- neurofeedback -- pharmacological treatment -- behavior therapy -- ADHD; Attention-deficit hyperactivity disorder -- Periodicals; Attention -- Periodicals; 616.8589
• DOI: 10.1177/1087054717693371
• Languages: English
• ISSNs: 1087-0547

Abstract

Objective: To examine the efficacy of neurofeedback (NF), behavior therapy (BT), and pharmacology (PH) on the improvement of ADHD-related symptoms.Method: Fifty-nine children with ADHD ( M = 8.80 years, SD = 1.92 years) were randomly assigned to one of the three treatments in a pre/post assessment design. Mother- and teacher-rated ADHD scales and children were assessed using The Integrated Visual and Auditory Continuous Performance Test (IVA/CPT).Results: The three treatments were effective on the IVA/CPT, but with different trends. BT and especially NF achieved improvement on response control and attention, and PH mainly in visual attention. On the rating scales, BT improved all measures, and NF and PH had a minor but interesting influence.Conclusion: From a global perspective, behavior therapy had the most extensive results, but PH had the greatest capacity to improve overall attention. NF was able to improve both control response and inattention. Clinical implications are discussed.